Bibliographic information
GuidelineUpdated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
Year of Publication2018
Issuing InstitutionWHO
Recommendation
Maintained
Originally developed
Adults and adolescents. Dolutegravir (DTG) is recommended as the preferred third drug for HIV postexposure prophylaxis
Recommended in favor
Strong
Certainty of evidence
Low
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Guidelines for HIV post-exposure prophylaxis
Year2025
InstitutionWorld Health Organization